One FTSE 250 growth stock I’d buy right now, and one I’d avoid

G A Chester discusses the prospects for two FTSE 250 (INDEXFTSE:MCX) growth candidates.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares of Fidessa (LSE: FDSA) are trading modestly higher after the FTSE 250 firm released its first-half results this morning. The provider of high-performance trading, investment management and information solutions for the world’s financial community said it had made “steady progress” during the period, with “solid revenue growth across all business lines and regions.”

Long-term opportunities

The company benefitted from the weakness of sterling, with 2% constant-currency revenue growth boosted to 12% at actual exchange rates. Similarly, a 2% increase in profit before tax at constant currency (excluding legitimate one-off costs of an office move) was boosted to 14% at actual exchange rates.

As has been the case for some time, political uncertainty, structural and regulatory changes are continuing to have an impact on the market conditions being faced by Fidessa’s customers. However, near-term prospects appear to be improving, with the company noting that delays in customer decision-making started to ease slightly during Q2. Longer-term, it maintains it’s well positioned to benefit from the opportunities presented by regulatory and structural change.

Good value

The company had cash of £71m and no debt at the half-year-end. It continues to be a strong generator of cash, even in the less-than-ideal conditions that have prevailed of late. For example, the board paid a 50p-a-share special dividend last year alongside an ordinary dividend of 42.5p and the City expects more of the same this year. A total payout of 94p is pencilled-in, giving an attractive yield of 4.1% at a share price of 2,300p.

Less attractive, on the face of it, is Fidessa’s earnings multiple of 24.7. However, taking into account the company’s strong cash position and what I view as its sound long-term prospects for earnings and dividend growth, I reckon the business is good value for its £890m market cap and I’d buy a slice of it today.

Updated old school

At a share price of around 3,600p, Metro Bank (LSE: MTRO) has a market cap of £3.2bn, trades on an earnings multiple of 124 and pays no dividend.

This challenger bank has a strategy that flies in the face of current banking orthodoxy. It’s opening branches rather than closing them, opening them for longer hours, including evenings and weekends, and making them dog-friendly and child-friendly among other things.

It’s a strategy that billionaire founder and chairman Vernon W Hill II employed successfully with Commerce Bancorp in the US between 1973 and 2007. Metro is currently growing its number of customers — or “fans” as Mr Hill prefers to call them — at a grand old rate and last week raised a further £278m from investors “in order to support this momentum and the company’s future growth ambitions.”

Despite the enthusiasm of its backers, I’ve marked this stock as one I’m avoiding. While the business looks set for terrific growth from a low base in the near term, this looks to be baked-in to the current valuation. Perhaps more importantly is the longer term. I have doubts about whether Metro’s business model will have fans flocking to it in 10, 20, or 30 years’ time. I fear updated old-school may not have a long shelf life as the 21st century rolls on.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended Fidessa. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »

Investing Articles

3 top Vanguard ETFs to consider for an ISA or SIPP in 2026

Edward Sheldon believes that these three Vanguard ETFs could be solid investments for a pension (SIPP) or investment account in…

Read more »

Investing Articles

5 growth stocks on Dr James Fox’s watchlist for 2026

Dr James Fox believes these UK and US growth stocks are worth considering as he looks to outperform the stock…

Read more »